POP-OUT | CLOSE

An Information Portal to 105339 Biological Macromolecular Structures

 
GLYCINE
 
GLY is found in 101946 entries
GLY
  •   Chemical Component Summary   Hide
    Name GLYCINE
    Identifiers 2-aminoethanoic acid
    Formula C2 H5 N O2
    Molecular Weight 75.07 g/mol
    Type peptide linking
    Isomeric SMILES
    InChI
    InChI key DHMQDGOQFOQNFH-UHFFFAOYSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00145   (Stereoisomeric match)
    Name Glycine
    Groups
    • approved
    • nutraceutical
    Description A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [PubChem]
    Synonyms
    • Aminoacetic acid
    • Aminoessigsaeure
    • Aminoethanoic acid
    • G
    • Gly
    • Glycin
    • Glycine
    • Glycocoll
    • Glykokoll
    • Glyzin
    • H2N-CH2-COOH
    • Hgly
    • Leimzucker
    [more]
    Brand names Gyn-Hydralin
    Affected organism Humans and other mammals
    Indication Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
    Pharmacology Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.
    Mechanism of action In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. <br/>Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS.
    Route of administration
    • Intraperitoneal
    • Irrigation
    Categories
    • Glycine Agents
    • Dietary Supplements
    • Micronutrients
    • Supplements
    • Non-Essential Amino Acids
    ATC-Code
    • B03AA01
    • B05CX03
    AHFS-Code 40:36.00
    CAS number 56-40-6
    Targets
    Name Sequence search Pharmacological action Actions
    Glycine receptor subunit beta   Search  unknown
    Glycine receptor subunit beta   Search  unknown
    Alanine--glyoxylate aminotransferase 2, mitochondrial   Search  unknown
    Glutathione synthetase   Search  unknown
    Serine hydroxymethyltransferase, mitochondrial   Search  unknown
    [more]
     
Ligand Image